Links 🖇️

Pitch Deck / Website / March Funding Announcement

Journey ⛰️

Asclepii is a Cleveland-based regenerative medicine startup revolutionizing wound care with cost-disruptive, innovative therapies. Led by a talented team, including CEO Franco Kraiselburd and COO William Tavel, the company has developed Artemis, a $5 scaffold, and Poseidon, an FDA-cleared hydrogel launching in July 2025. With $500K secured from Zentynel Frontier Investments and $1M in non-dilutive funding, Asclepii is scaling its solutions, which slash treatment costs from $30K to $300. Recognized as an Elite 8 finalist at Midwest House for SXSW and a strong contender in multiple startup competitions, Asclepii is poised to transform the wound care landscape.

Location 🗺️

HQ: 11201 Cedar Ave Suite #600, Cleveland, Ohio 

Leadership 🤼 

Contact email: franco@asclepii.com

• Franco Kraiselburd (CEO)
• Ixchel Robles (CTO/CPO, Technology/Product)
• Miguel Fuentes (CSO, Scientific)
• Vicki Fischenich (CCO, Clinical)

Alignment 💫

• Seed Stage startup with working MVP
• Completed R&D protocol
• Signed CDMO (Contract Development and Manufacturing Organization)
• Clinical immersion with hundreds of physicians
• Participated in I-Corps program
• Focus areas: Chronic wounds, Acute wounds, Regenerative Medicine
• Key Partnerships:
  • Viscus Biologics
  • JumpStart
  • Case Western Reserve University
  • University Hospitals
  • Universidad Valparaiso
  • TEC
  • Capital Factory

Round Details 💰

Ask Pauly or reach out to the leadership team above for more details.

Asks 🙋

• Support in obtaining 510(k) clearance
• Assistance in market entry strategy
• Help expanding product portfolio
• Introductions to medical device investors
• Clinical network expansion